https://alveustx.com/news/alveus-therapeutics-announces-fda-clearance-of-ind-and-first-patient-dosed-in-phase-1b-trial-of-alv-100-for-obesity/

Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity